Iridoids modulate inflammation in diabetic kidney disease: A review.
J Integr Med
; 22(3): 210-222, 2024 May.
Article
en En
| MEDLINE
| ID: mdl-38631983
ABSTRACT
In recent years, preclinical research on diabetic kidney disease (DKD) has surged to the forefront of scientific and clinical attention. DKD has become a pervasive complication of type 2 diabetes. Given the complexity of its etiology and pathological mechanisms, current interventions, including drugs, dietary modifications, exercise, hypoglycemic treatments and lipid-lowering methods, often fall short in achieving desired therapeutic outcomes. Iridoids, primarily derived from the potent components of traditional herbs, have been the subject of long-standing research. Preclinical data suggest that iridoids possess notable renal protective properties; however, there has been no summary of the research on their efficacy in the management and treatment of DKD. This article consolidates findings from in vivo and in vitro research on iridoids in the context of DKD and highlights their shared anti-inflammatory activities in treating this condition. Additionally, it explores how certain iridoid components modify their chemical structures through the regulation of intestinal flora, potentially bolstering their therapeutic effects. This review provides a focused examination of the mechanisms through which iridoids may prevent or treat DKD, offering valuable insights for future research endeavors. Please cite this article as Zhou TY, Tian N, Li L, Yu R. Iridoids modulate inflammation in diabetic kidney disease A review. J Integr Med. 2024; 22(3) 210-222.
Palabras clave
Texto completo:
1
Bases de datos:
MEDLINE
Asunto principal:
Iridoides
/
Nefropatías Diabéticas
Idioma:
En
Revista:
J Integr Med
Año:
2024
Tipo del documento:
Article
País de afiliación:
China